Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Diffuse Scleroderma. Strongest funded area: Basic Science. Largest gap: Epidemiology / Natural History.
Clinical ResearchTrials Active, No NIH Grants
114 clinical trials registered but no NIH-funded clinical or translational research grants found for diffuse scleroderma. Trials may be industry-sponsored or funded through non-NIH sources.
Epidemiology / Natural HistoryPublished, Not NIH-Funded
21 publications in Case Report / Case Series but no NIH-funded grants found in Epidemiology / Natural History for diffuse scleroderma. Existing research activity suggests this may be a viable area for grant applications.
Clinical ResearchPublished, Not NIH-Funded
5 publications in Clinical Trial Publication but no NIH-funded grants found in Clinical Research for diffuse scleroderma. Existing research activity suggests this may be a viable area for grant applications.
Epidemiology / Natural HistoryPublished, Not NIH-Funded
11 publications in Epidemiology / Natural History but no NIH-funded grants found in Epidemiology / Natural History for diffuse scleroderma. Existing research activity suggests this may be a viable area for grant applications.
Adjacent Research(1 grant)
These grants mention Diffuse Scleroderma as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.
Other(1)
OtherR01Active
Assessing spatial frequency domain imaging as an objective quantification of longitudinal skin changes in scleroderma
Bujor, Andreea et al.·BOSTON UNIVERSITY MEDICAL CAMPUS·BOSTON, MA
